Sanjivani Paranterals (BOM:531569) Net Income From Continuing Operations : ₹80.9 Mil (TTM As of Mar. 2025)

View and export this data going back to 2001. Start your Free Trial

What is Sanjivani Paranterals Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Sanjivani Paranterals's net income from continuing operations for the three months ended in Mar. 2025 was ₹21.9 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ₹80.9 Mil.

Sanjivani Paranterals Net Income From Continuing Operations Historical Data

The historical data trend for Sanjivani Paranterals's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanjivani Paranterals Net Income From Continuing Operations Chart

Sanjivani Paranterals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Income From Continuing Operations

Get a 7-Day Free Trial

14.12

48.79

49.44

75.72

103.52

Sanjivani Paranterals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															12.58	17.14	22.96	18.98	21.86

Sanjivani Paranterals Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹80.9 Mil.

Sanjivani Paranterals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanjivani Paranterals Ltd (BOM:531569) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

N/A

Address

Asha Nagar Park Road, 1202, B-Wing, O2 Business Commercial Park, Mulund (West), Mumbai, MH, IND, 400080

Website

https://www.sanjivani.co.in

Sanjivani Paranterals Ltd is a pharmaceutical company principally engaged in providing pharmaceutical products and services. The company's main product range includes oral solids and small-volume parenteral and sterile powder formulations. The products offered by the company are anti-biotic, anti-emetic, anti-tuberculosis, anti-diabetic, anti-malarial, anti-fungal, calcium and vitamin, multivitamin, sedative, cardiovascular, anti-gout, and others. The company also provides Liquid Injection, Dry powder Injection, Capsules, Drops, and others. The firm sells its products in India and internationally.

Sanjivani Paranterals Headlines

No Headlines